Dimopoulos, M.A. Niesvizky, R. Weisel, K. Siegel, D.S. Hajek, R. Mateos, M.-V. Cavo, M. Huang, M. Zahlten-Kumeli, A. Moreau, P., Once- versus twice-weekly carfilzomib in relapsed and refractory multiple myeloma by select patient characteristics: phase 3 A.R.R.O.W. study subgroup analysis, Blood cancer journal, (10), 2020, Springer Nature BV,